methylprednisolone acetate has been researched along with Lung Neoplasms in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cowled, PA | 1 |
| Mackenzie, L | 1 |
| Forbes, IJ | 1 |
1 other study available for methylprednisolone acetate and Lung Neoplasms
| Article | Year |
|---|---|
Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids.
Topics: Animals; Cell Line; Drug Interactions; Glucocorticoids; Hematoporphyrin Photoradiation; Hydrocortiso | 1985 |